Skip to main content
Figure 1 | BMC Infectious Diseases

Figure 1

From: The safety and immunogenicity of a MF59-adjuvanted H5N1 prepandemic influenza vaccine in healthy adults primed with homologous or heterologous H5N1 vaccines: an observational study

Figure 1

Study design. AS03-adjuvanted split virion A/Vietnam/1194/2004 vaccine was provided and primed in March and April, 2008. Non-adjuvanted whole virion A/Indonesia/05/2005 vaccine was provided and primed in August and September, 2010. The study vaccine of MF59-adjuvanted split virion A/Vietnam/1194/2004 virus was administered in Jun and July, 2011. Each course of vaccine administration included two doses of immunization apart by three weeks. Arrow indicates blood sampling for Hemagglutination inhibition test.

Back to article page